Nifty
Sensex
:
:
15746.45
52578.76
-78.00 (-0.49%)
-316.65 (-0.60%)

Pharmaceuticals & Drugs - Domestic

Rating :
55/99

BSE: 531599 | NSE: FDC

376.10
26-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  381.50
  •  384.70
  •  375.30
  •  379.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  128006
  •  487.16
  •  404.90
  •  255.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,346.42
  • 21.06
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,319.89
  • 0.21%
  • 3.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.35%
  • 1.71%
  • 16.82%
  • FII
  • DII
  • Others
  • 4.76%
  • 4.28%
  • 3.08%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.57
  • 6.22
  • 7.73

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.85
  • 5.07
  • 5.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.79
  • 7.33
  • 11.45

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.74
  • 19.71
  • 18.67

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.03
  • 2.98
  • 2.77

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.26
  • 12.83
  • 12.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
313.40
333.33
-5.98%
340.23
321.22
5.92%
371.39
346.12
7.30%
308.18
343.52
-10.29%
Expenses
261.79
304.04
-13.90%
266.50
236.49
12.69%
265.68
272.25
-2.41%
204.60
265.04
-22.80%
EBITDA
51.61
29.29
76.20%
73.73
84.73
-12.98%
105.72
73.87
43.12%
103.58
78.48
31.98%
EBIDTM
16.47%
8.79%
21.67%
26.38%
28.47%
21.34%
33.61%
22.84%
Other Income
14.97
37.76
-60.35%
35.05
31.03
12.96%
19.04
16.90
12.66%
27.97
9.79
185.70%
Interest
1.07
0.99
8.08%
0.80
0.79
1.27%
0.82
0.82
0.00%
0.75
0.81
-7.41%
Depreciation
9.54
9.32
2.36%
9.19
9.20
-0.11%
9.65
9.57
0.84%
9.44
9.36
0.85%
PBT
53.85
56.73
-5.08%
98.78
105.77
-6.61%
114.29
80.38
42.19%
121.36
78.09
55.41%
Tax
7.09
0.86
724.42%
23.57
31.51
-25.20%
26.43
25.97
1.77%
29.44
21.73
35.48%
PAT
46.76
55.88
-16.32%
75.21
74.25
1.29%
87.86
54.41
61.48%
91.92
56.36
63.09%
PATM
14.92%
16.76%
22.11%
23.12%
23.66%
15.72%
29.83%
16.41%
EPS
2.78
3.25
-14.46%
4.46
4.34
2.76%
5.15
3.16
62.97%
5.36
3.21
66.98%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,333.20
1,344.19
1,090.70
1,075.07
1,013.87
994.32
889.31
845.85
772.83
710.54
711.67
Net Sales Growth
-0.82%
23.24%
1.45%
6.04%
1.97%
11.81%
5.14%
9.45%
8.77%
-0.16%
 
Cost Of Goods Sold
413.49
425.72
345.14
352.08
339.05
357.93
272.91
266.16
311.11
237.54
253.93
Gross Profit
919.71
918.46
745.56
722.99
674.81
636.38
616.40
579.69
461.71
473.00
457.75
GP Margin
68.99%
68.33%
68.36%
67.25%
66.56%
64.00%
69.31%
68.53%
59.74%
66.57%
64.32%
Total Expenditure
998.57
1,051.25
859.68
848.38
770.40
765.58
690.76
641.47
591.97
547.15
545.76
Power & Fuel Cost
-
27.40
24.61
22.00
21.55
23.14
20.18
18.45
16.85
13.77
12.73
% Of Sales
-
2.04%
2.26%
2.05%
2.13%
2.33%
2.27%
2.18%
2.18%
1.94%
1.79%
Employee Cost
-
277.48
225.57
216.67
191.08
175.76
137.58
122.05
107.52
99.02
85.57
% Of Sales
-
20.64%
20.68%
20.15%
18.85%
17.68%
15.47%
14.43%
13.91%
13.94%
12.02%
Manufacturing Exp.
-
61.14
62.25
58.77
49.40
36.44
97.27
88.65
22.88
70.20
67.06
% Of Sales
-
4.55%
5.71%
5.47%
4.87%
3.66%
10.94%
10.48%
2.96%
9.88%
9.42%
General & Admin Exp.
-
58.06
59.45
61.55
53.35
49.97
41.43
35.99
34.32
33.79
31.76
% Of Sales
-
4.32%
5.45%
5.73%
5.26%
5.03%
4.66%
4.25%
4.44%
4.76%
4.46%
Selling & Distn. Exp.
-
94.70
78.92
75.96
64.36
57.73
64.96
58.43
56.15
55.45
55.12
% Of Sales
-
7.05%
7.24%
7.07%
6.35%
5.81%
7.30%
6.91%
7.27%
7.80%
7.75%
Miscellaneous Exp.
-
106.74
63.73
61.35
51.61
64.61
56.43
51.73
43.13
37.36
55.12
% Of Sales
-
7.94%
5.84%
5.71%
5.09%
6.50%
6.35%
6.12%
5.58%
5.26%
5.56%
EBITDA
334.64
292.94
231.02
226.69
243.47
228.74
198.55
204.38
180.86
163.39
165.91
EBITDA Margin
25.10%
21.79%
21.18%
21.09%
24.01%
23.00%
22.33%
24.16%
23.40%
23.00%
23.31%
Other Income
97.03
68.90
43.47
50.96
50.22
39.00
45.72
42.00
46.36
28.65
28.25
Interest
3.44
3.42
1.44
1.40
1.41
1.40
1.81
3.10
1.60
1.41
1.44
Depreciation
37.82
37.46
33.24
35.14
34.62
33.73
38.81
24.91
27.90
18.43
17.36
PBT
388.28
320.97
239.80
241.11
257.65
232.62
203.65
218.36
197.72
172.20
175.37
Tax
86.53
80.08
66.85
67.12
63.30
63.48
55.51
83.04
42.55
38.11
24.48
Tax Rate
22.29%
24.95%
28.01%
27.84%
25.14%
27.29%
27.26%
38.03%
21.52%
22.13%
13.96%
PAT
301.75
240.89
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
PAT before Minority Interest
301.89
240.89
171.85
173.99
188.47
169.14
148.15
135.32
155.17
134.09
150.89
Minority Interest
0.14
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
22.63%
17.92%
15.76%
16.18%
18.59%
17.01%
16.66%
16.00%
20.08%
18.87%
21.20%
PAT Growth
25.26%
40.17%
-1.23%
-7.68%
11.43%
14.17%
9.48%
-12.79%
15.72%
-11.13%
 
EPS
17.88
14.27
10.18
10.31
11.17
10.02
8.78
8.02
9.19
7.94
8.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,547.43
1,445.24
1,276.11
1,270.20
1,082.47
936.38
845.30
784.24
695.42
616.39
Share Capital
17.10
17.52
17.52
17.86
17.86
17.86
17.86
18.16
18.37
18.54
Total Reserves
1,530.33
1,427.72
1,258.59
1,252.34
1,064.61
918.52
827.43
766.08
677.05
597.86
Non-Current Liabilities
314.62
229.17
211.41
216.67
19.93
24.06
30.97
31.32
30.24
29.59
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.22
0.56
0.77
Unsecured Loans
0.34
0.49
0.60
0.69
0.79
0.90
1.07
1.24
1.45
1.73
Long Term Provisions
295.78
213.96
194.12
198.60
0.50
0.56
0.00
0.00
0.00
2.20
Current Liabilities
564.62
497.43
480.07
389.40
163.42
187.97
195.69
153.97
139.01
123.45
Trade Payables
117.86
77.61
97.32
75.10
82.59
87.17
80.05
61.04
57.64
45.90
Other Current Liabilities
80.06
61.67
68.78
64.11
50.16
36.61
42.87
35.98
30.09
29.60
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
1.00
1.11
1.14
1.29
1.27
Short Term Provisions
366.69
358.15
313.97
250.19
30.67
63.19
71.66
55.81
49.99
46.68
Total Liabilities
2,426.67
2,171.84
1,967.59
1,876.27
1,265.82
1,148.41
1,071.96
969.53
864.67
769.43
Net Block
673.50
682.19
673.64
678.05
675.16
393.04
284.40
289.19
293.04
276.74
Gross Block
844.97
817.80
776.49
745.84
708.81
629.67
470.42
453.02
430.01
396.15
Accumulated Depreciation
171.47
135.61
102.84
67.79
33.65
236.62
186.02
163.82
136.96
119.41
Non Current Assets
1,181.25
1,113.46
976.64
957.93
742.46
646.27
619.47
558.20
418.02
322.50
Capital Work in Progress
23.85
12.38
12.84
6.32
19.92
28.80
18.10
7.22
10.72
10.18
Non Current Investment
162.31
179.11
74.07
54.49
39.43
216.72
186.92
245.15
96.20
14.01
Long Term Loans & Adv.
320.83
239.08
215.28
218.46
7.70
6.37
128.71
15.13
17.41
19.42
Other Non Current Assets
0.75
0.71
0.81
0.60
0.25
1.33
1.33
1.51
0.65
2.15
Current Assets
1,245.41
1,058.38
990.94
918.34
523.36
502.13
452.03
410.83
446.10
446.88
Current Investments
502.24
405.93
397.16
436.53
285.41
272.49
229.90
170.91
243.92
248.86
Inventories
209.96
173.79
160.49
137.16
130.91
123.22
103.00
99.71
102.92
97.42
Sundry Debtors
123.74
87.53
81.66
76.06
61.94
61.04
59.36
43.23
41.97
40.75
Cash & Bank
32.32
21.26
29.30
28.47
18.02
14.95
23.43
36.50
16.78
17.76
Other Current Assets
377.15
11.32
10.68
9.68
27.10
30.44
36.33
60.49
40.52
42.09
Short Term Loans & Adv.
350.34
358.56
311.65
230.44
20.36
14.77
28.18
48.89
34.66
39.71
Net Current Assets
680.79
560.94
510.87
528.94
359.94
314.16
256.33
256.86
307.09
323.43
Total Assets
2,426.66
2,171.84
1,967.58
1,876.27
1,265.82
1,148.40
1,071.97
969.53
864.66
769.44

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
250.38
112.43
149.84
154.49
174.30
127.64
149.72
149.94
144.33
120.74
PBT
319.95
237.75
240.63
257.71
232.15
203.65
218.36
197.72
172.20
175.37
Adjustment
22.58
-0.21
0.39
-10.88
2.41
-1.40
-7.67
-14.20
-2.62
1.31
Changes in Working Capital
-7.77
-51.05
-23.24
-19.23
-4.54
-11.78
7.09
4.14
9.01
-20.98
Cash after chg. in Working capital
334.77
186.49
217.78
227.60
230.02
190.48
217.79
187.66
178.59
155.70
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-84.39
-74.06
-67.94
-70.14
-55.73
-62.84
-68.07
-37.72
-34.26
-34.97
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-2.97
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-98.35
-120.33
20.11
-143.55
-73.05
-88.57
-55.38
-107.18
-108.25
-33.00
Net Fixed Assets
-38.52
-40.93
-36.71
-24.24
-81.62
-169.89
-28.28
-19.51
-25.53
-17.54
Net Investments
-79.51
-113.70
19.79
-166.18
170.44
-72.39
-0.76
-75.95
-83.31
-33.71
Others
19.68
34.30
37.03
46.87
-161.87
153.71
-26.34
-11.72
0.59
18.25
Cash from Financing Activity
-142.00
-0.07
-169.43
0.35
-96.98
-47.76
-75.25
-62.83
-58.18
-57.51
Net Cash Inflow / Outflow
10.03
-7.96
0.52
11.29
4.27
-8.69
19.09
-20.06
-22.10
30.22
Opening Cash & Equivalents
19.92
28.13
27.10
16.25
12.17
23.26
4.17
24.23
46.33
16.11
Closing Cash & Equivalent
29.88
19.92
28.13
27.10
16.25
14.56
23.26
4.17
24.23
46.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
90.51
82.86
73.17
71.42
60.87
52.62
47.47
43.30
37.95
33.35
ROA
10.48%
8.30%
9.05%
12.00%
14.01%
13.34%
13.26%
16.92%
16.41%
20.83%
ROE
16.10%
12.63%
13.67%
16.02%
16.76%
16.64%
16.63%
21.01%
20.48%
26.44%
ROCE
21.63%
17.64%
19.04%
21.51%
23.15%
23.02%
27.12%
26.85%
26.34%
30.73%
Fixed Asset Turnover
1.66
1.41
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
Receivable days
27.96
27.55
26.58
23.96
22.06
24.19
21.70
19.72
20.88
19.59
Inventory Days
50.80
54.43
50.15
46.55
45.58
45.45
42.89
46.90
50.57
47.41
Payable days
38.50
40.35
41.32
40.83
44.81
47.89
44.12
40.39
37.33
32.94
Cash Conversion Cycle
40.26
41.62
35.41
29.68
22.84
21.74
20.47
26.23
34.12
34.06
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Interest Cover
94.95
166.95
172.62
179.60
167.11
113.30
71.41
124.23
122.88
122.86

News Update:


  • FDC launches oral suspension of Favipiravir
    12th Jul 2021, 16:43 PM

    This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.